"Designing Growth Strategies is in our DNA"

Transthyretin Amyloidosis Treatment Market Size, Share & Industry Analysis, By Drug (Inostersen, Partisiran, Tafamidis, Others), By Indication (Wild Type ATTR amyloidosis, Hereditary ATTR amyloidosis), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) and Regional Forecast, 2023-2030

Region : Global | Report ID: FBI101886 | Status : Ongoing

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Final report will be updated to address the impact of COVID-19 on this particular market

Request PDF Brochure

Refresh Button
Booklet
  • Ongoing
  • 2021
  • 2018-2020

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $6850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X